What Kind of Studies Would Help the Task Force?

We still don't have a lot of evidence yet for the longer term issues, but there are treatments. Most of them are actually restricted to people with significant OSA. It would be great if you can look at the predictive ability of those tools in the general populations of those without signs or symptoms. And then finally, it's still not clear how specifically OSA itself contributes to poor outcomes.